A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples